Pharmaceutical Industry Information Portal

HomeDiscovery and Development

Discovery and Development

Walter Reed Army Institute of Research Continues Recruitment for COVID-19 Clinical Trial

The vaccine, called spike ferritin nanoparticle (SpFN), stands out in the COVID-19 vaccine landscape. Scientists developed a nanoparticle vaccine, based on a ferritin platform,...

Biokhimik JSC of Promomed Group and Mordovia State University agreed on further cooperation

At the meeting of the management of Biokhimik JSC with Acting Rector of the Ogarev Mordovia State University Dmitry Glushko and the scientific community...

A Clinical Trial of a Russian Originator for the Treatment of Cervical Cancer Started in China

A joint venture between the biotechnology company BIOCAD and Shanghai Pharmaceuticals Holding has announced the enrollment of the first patient in a trial of...

R-Pharm presented results of phase III global research program for rheumatoid arthritis drug, novel IL-6 inhibitor Olokizumab

In the framework of the annual ACR Convergence 2021, R-Pharm Group presented successful results of olokizumab in two randomized clinical trials of phase III...

R-Pharm presented results of phase III global research program – CREDO

In the framework of the annual ACR Convergence 2021, R-Pharm Group presented successful results of olokizumab in two randomized clinical trials of phase III global research program — CREDO (Clinical RhEumatoid Arthritis Development...

Research Center of Mendeleev University and Ferring will develop innovative pharmaceuticals for Russia

The research center of the university will be engaged in the development of new drugs for Russia with improved characteristics of safety and bioavailability profiles, increased stability and ease of use. First of all, they will be innovative pharmaceuticals for women's health, reproductive medicine, neurology and immunology.
spot_img

Expert Articles

spot_img